Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Datascan Helps Independent Pharmacies Compete on the Open Market


Datascan Pharmacy Solutions

Datascan Pharmacy Software

Getting your Pharmacy start-up off on the right foot is key to your success. Let our software help guide you to a smooth and profitable grand opening

Since 1981, Datascan has been providing advanced technology through their affordable pharmacy software solutions to independent retail pharmacies, doctors dispensaries, long term care management companies, as well as hospital / out-patient care pharmacies across the USA. Datascan’s software is designed to streamline pharmacy workflow while building profits, efficiency, and patient adherence. Many of Datascan’s clients report a 10-20% rise in profits following the software’s implementation.

Datascan’s pharmacy software products are backed by a customer support system that’s unmatched in the industry. Its customer service calls are often answered within 60 seconds – the fastest recorded response time in the industry.

Customer service efforts are so personalized that the majority of Datascan’s client feedback and ideas are worked into the software. More than 50% of client suggestions have been written into the software over time, ensuring that the client needs are met, even in the face of a constantly changing market.

Datascan was one of the first Windows-based pharmacy management systems on the market. They were also the first to offer a point of sale (POS) system made specifically for pharmacy – one of the first to offer a medication synchronization program built directly into the software and the first company to build a pharmacy delivery system on the Android market so that iPads were no longer a required business expense.

Datascan has consistently been ahead of the competition with first to market features, achieving a loyal customer base – 45% have been Datascan clients for more than 20 years.

Pharmacy software helps independent dispensaries reduce staff time through automation features – which when utilized to their full extent, can help to increase profits, reduce staffing needs, and lower operating costs.

Datascan’s pharmacy software offers the simplest way for an independent pharmacy to modernize their business and keep ahead of chain stores. Datascan has proven that providing high quality, quick response service gives them a competitive edge and a successful business model. Datascan gives their clients the ability to provide the same quality service to their customers ensuring customer retention and a name their patients are proud to recommend.

About Datascan:

For almost 40 years, family-owned Datascan has been the pioneer of the pharmacy software industry. Our client-focused features are designed to tackle DIR fees, increase profits, and build customer retention. Datascan supports the evolution of the pharmacy industry and as your needs change we are ahead of the competition with first to market features built in house, directly into your pharmacy software system.

Facebook:

https://www.facebook.com/Datascanpharmacysoftware/

Linkedin

https://www.linkedin.com/company/datascan-pharmacy-software

Share article on social media or email:

ProMach Strengthens Pharmaceutical Portfolio with Acquisition of Pharmaworks


“With the addition of Pharmaworks, ProMach can now meet nearly any pharmaceutical customer’s packaging needs – whether it’s in rigid bottles or flexible blister packs – and help them grow their business with a proven partner.” – Michel Lapierre, ProMach, President, Pharma Business Line

ProMach, a worldwide leader in packaging machinery solutions, announced today it has acquired Pharmaworks, a leading provider of blister packaging technology for the pharmaceutical, consumer goods, and contract packaging industries. The addition of Florida-based Pharmaworks significantly expands ProMach’s portfolio of pharmaceutical solutions and strengthens its integrated solutions capabilities for a broad range of applications.

Pharmaworks, founded in 2001, offers a robust and flexible lineup of themoforming solutions for the creation of blister packs, a packaging format commonly used in over-the-counter (OTC) and prescription unit dose pharmaceutical and consumer goods packaging. Pharmaworks blister packaging solutions range from semi-automated thermoformers to fully automated systems capable of speeds up to 600 packages per minute. In addition to their core blister packaging machinery, Pharmaworks also provides feeding, transferring, collating, cartoning, and vision/inspection systems, as well as a comprehensive aftermarket support program with parts, service, machinery rebuilds/upgrades, controls upgrades, tooling, accessories, and much more. Additionally, Pharmaworks provides complete blister line integration services for customers needing turnkey blister packaging lines, complete with validation documentation.

“We’re pleased to welcome the Pharmaworks team to ProMach,” said Mark Anderson, ProMach President and CEO. “The pharmaceutical industry has been a strong growth engine for ProMach over the last five years, beginning with our acquisition of NJM in 2016 and continuing with the addition of WLS in 2017 and now Pharmaworks in 2020. The research forecasts continued strong growth in the pharmaceutical sector over the next few years, and blister packs are a key part of that growth story driven by consumer convenience and safety, particularly with regulations around serialization. I am excited to work with the outstanding senior leadership team at Pharmaworks as they continue developing new innovative solutions, expanding into new markets, and growing their already successful business to even greater heights.”

Odessa, Florida-based Pharmaworks and its over 100 employees are joining the ProMach team. Current Pharmaworks President, Peter Buczynsky, will join ProMach as Vice President and General Manager of Pharmaworks. He will be joined by Ingo Federle, Vice President of Technical Operations, and Ben Brower, Vice President of Sales & Marketing.

“ProMach is well regarded in the packaging machinery marketplace for many of the same things that have made Pharmaworks successful – quality, reliability, flexibility, innovation, and integrity,” said Mr. Buczynsky. “Our passion to engineer solutions for pharmaceutical packaging remains at the heart of our business and this deal lets us continue to expand our products, accelerate our pace of innovation, expand our manufacturing operations, more quickly add talented team members, and most importantly create additional value for Pharmaworks customers across the globe. We are looking forward to working with the entire ProMach team to continue this journey we embarked on nearly two decades ago.”

“Many of our customers want a full range of pharmaceutical packaging options from a single source,” said Michel Lapierre, President of ProMach’s Pharma Business Line. “With the addition of Pharmaworks, ProMach can now meet nearly any customer’s needs – whether it’s in rigid bottles or flexible blister packs, from solid dose tablets, capsules, and lozenges to liquid vials, ampoules, and pre-filled syringes – and help them grow their business with a proven partner.”

For more information about Pharmaworks please call +1 (727) 232-8200 or visit them online at http://www.Pharmaworks.com.

About ProMach

ProMach is a family of best-in-class packaging solution brands serving manufacturers of all sizes and geographies in the food, beverage, pharmaceutical, personal care, and household and industrial goods industries. ProMach brands operate across the entire packaging spectrum: filling and capping, flexibles, pharma, product handling, labeling and coding, and end of line. ProMach also provides complete turnkey packaging lines, including engineering services, integration, and software to optimize packaging line design and deliver maximum uptime.

ProMach designs, manufactures, integrates, and supports the most sophisticated and advanced packaging solutions in the global marketplace. Its diverse customer base, from Fortune 500 companies to smaller, privately-held businesses worldwide, depends on reliable, flexible, technologically advanced equipment and integrated solutions. ProMach is headquartered near Cincinnati, Ohio, with manufacturing facilities and offices throughout North America, Europe, South America, and Asia. For more information about ProMach, visit http://www.ProMachBuilt.com.

Share article on social media or email:

Dr. Richard E. Buckley Comments on the Rise of Earlobe Reconstruction Surgery Requests After Kelly Ripa’s Ear Reveal


Earlobe repair surgery by Dr. Richard E. Buckley

Kelly Ripa recently revealed she underwent earlobe reconstructive surgery. Dr. Richard E. Buckley discusses why torn earlobes is not the only reason clients are seeking out this surgical procedure.

Whether the earlobe is stretched purposely or accidentally over time due to heavy earrings or trauma, they can be reduced and reshaped to have pleasing, natural-looking contours, and, more excitingly, normal functionality with the ability to wear earrings again.

When people think about reconstructive earlobe surgery it’s most often thought of in relation to the early 2000 trend for “gauged” earlobes, which is a body modification where an individual would stretch their ears by continually using slightly larger jewelry to create larger than typical pierced holes. But “gauged” or purposely super-sized earlobe holes are not the only reason individuals are seeking out earlobe reconstructive surgery. “At MilfordMD there has been an increase in men and women requesting repair of their earlobes. In most cases it is due to earrings having partially or wholly torn the earlobes. Mostly not because the person purposely stretched their earlobes, but rather because of a history of wearing heavy earrings,” says Dr. Richard E. Buckley Cosmetic Surgeon and Medical Director of MilfordMD Cosmetic Dermatology Surgery & Laser Center in Milford, Penn.

During the Live with Kelly and Ryan! Fashion Finder segment on Instagram TV, Kelly Ripa shared that her earholes were torn all the way through as a result of wearing hanging earrings for years. “When this happens, it’s disheartening for patients. We frequently find out that a patient has gone fifteen to twenty years without earrings because of their torn earlobe. They are very excited to hear it can be repaired and that they can resume wearing earrings immediately following surgery,” according to Dr. Buckley.

In 2018, the ninth top cosmetic surgical procedure was earlobe surgery according to The American Society for Aesthetic Plastic Surgery revealing that it is a highly requested surgical procedure with 60% female patients and 40% male patients.

“Whether the surgery is desired because of distorted earlobes due to gauging or a result of years of heavy, hanging earrings, earlobe reconstructive surgery involves repairing the earlobe through and through. It’s not just the surface of the front of the ear that is repaired. It’s also the thickness of the ear where the scarring is removed and the backside of the ear where the ear is repaired. There is usually a bunch of scar tissue that is removed at the same time,” says Dr. Buckley.

Earlobe reconstructive surgery takes about thirty minutes per ear or one hour to repair both earlobes. The procedure uses local anesthetic, so patients are comfortable with minimal discomfort and are able to resume daily activities immediately following their surgery. Dr. Buckley recommends avoiding unclean water such as swimming pools and the ocean for two to three weeks following the surgery to minimize any infection risks.

For this type of reconstructive surgery, Dr. Richard E. Buckley taps into his surgical and artistic skills to re-shape the lobe. “The goal of this surgery is a normal contour of the earlobe. It’s important to craft the earlobes so they are aesthetically pleasing and natural-looking. The surgical process, crafting how the scarring is removed, and how the new fresh edges are put together is truly individualized. It’s in that process of individualization that the contours are restored,” says Dr. Buckley.

When reconstructing the earlobe, it’s not as simple as just sewing the top and bottom piece together. First, the healed part where the earring pulled through is removed. And the inner edges must be freshened as scar tissue can’t be pieced together. The scar tissue is removed so there is nice, fresh healthy skin to sew together. And it’s not simply two flat surfaces that are pieced together. Little steps or grooves in the shape of the letter ‘Z’ are made on each side, matched and stitched together, according to Dr. Buckley.

In the past, patients would have to wait until the repair healed before placing a new earring stud. Now, Dr. Buckley places new gold earring stud during the procedure. “What I often find is that the original earring placement is not truly symmetrical if you measure it,” says Dr. Buckley, “I make sure the new earring placements are truly symmetrical for patients.” Aftercare is a key component to a successful surgery. Patients need to turn the stud daily and keep antibiotic on the front and back side of the surgical area while it heals.

“There are many ways of crafting the earlobe repair so it is much stronger after surgery,” states Dr. Buckley. “It requires some finesse and utilization of fancy techniques which patients can’t really appreciate since it’s all inside the ear. But it makes a difference in how it heals and the future durability of the repair. This is where a surgeon’s skills and artistry come into play and that can make all the difference in the result.”

About MilfordMD Cosmetic Dermatology Surgery & Laser Center:

The MilfordMD Cosmetic Dermatology Surgery & Laser Center offers state-of-the-art highly specialized procedures in laser and cosmetic surgery and aesthetic skin care. In addition to its AAAHC nationally accredited surgical center and extensive laser surgery capabilities, MilfordMD offers physician designed skin care products for home use. Milford Pennsylvania’s MilfordMD Cosmetic Dermatology Surgery & Laser Center is sought out by patients from around the world for expertise and innovation in cosmetic treatments performed by Board Certified Physicians, Richard E. Buckley, M.D. and Marina Buckley, M.D.

MilfordMD Cosmetic Dermatology Surgery & Laser Center is located at 303 W. Harford Street, Milford, PA 18337. Tel: (570) 491-1962. For real patient video testimonials, follow MilfordMD on Instagram and Facebook, and visit our MilfordMD YouTube channel.

Share article on social media or email:



Two Windsor Care Centers Receive the Pinnacle Quality Insight 2020 Customer Experience Award


Pinnacle Customer Experience Award

Windsor Convalescent Center of North Long Beach, California and Encanto Palms Assisted Living in Phoenix, Arizona announced today that they are the recipients of Pinnacle Quality Insight’s 2020 Customer Experience AwardTM.

Pinnacle Quality Insight conducts thousands of monthly phone surveys to establish a comprehensive review of their clients and gauge resident satisfaction. Every year, Pinnacle awards clients who have excelled at providing a superior customer experience for their patients and residents. Out of 2,700 care providers and 150,000 customer interviews conducted each year, only those scoring in the top 15% across a 12-month average receive the award.

Clients who achieve a Customer Experience Award must score well in at least one of the following categories: Overall, satisfaction, Nursing Care, Dining Service, Quality of Food, Cleanliness, Individual Needs, Laundry Service, Communication from Facility, Response to Problems, Treatment/Dignity, Recommend Facility to Others, Recreational Activities, Professional Therapy Services, Admission Process, Overall Safety, Overall Customer Experience

“Throughout its history, Windsor has always placed a strong emphasis on ensuring that the individual needs of every resident are met,” says Mike Hurtado, Administrator at Windsor Convalescent Center of North Long Beach. “Over the course of 2019, a sampling of our residents and their families participated in monthly telephone interviews, and we are thrilled to be receive Pinnacle’s 2020 Customer Experience Award.”

“I feel privileged to serve with such amazing leaders as those at Encanto Palms Assisted Living,” adds Dr. Charles Villafranca, DHA(ABD), MSHA/HM, Administrator and Executive Director at Encanto Palms Assisted Living.

About Pinnacle Quality Insight

A customer satisfaction measurement firm with 24 years of experience in post-acute healthcare, Pinnacle conducts over 150,000 phone surveys each year and works with more than 2,500 care providers in all 50 US states, Canada and Puerto Rico.

About Windsor

Windsor Convalescent Center of North Long Beach and Encanto Palms Assisted Living are associated with Windsor healthcare centers. Windsor provides short-term and long-term healthcare, rehabilitation services and assisted living communities throughout California and Arizona. Windsor employs professionals that provide nursing, therapeutic, sub-acute and rehabilitation care to over 4,000 patients daily.

Share article on social media or email:

Frier Levitt Files Amicus Brief with Supreme Court on Behalf of Community Oncology Alliance and Leading Community Oncology Practices Supporting State Regulation of PBMs


The Constitution and Supreme Court precedent make clear that protecting the health and well-being of citizens is properly in the hands of the state lawmakers. It is critical that states have the right to enact laws protecting both patients and providers from PBM abuse,” Jonathan E. Levitt, Esq.

On March 2, 2020 Frier Levitt, a national boutique healthcare law firm, filed an Amicus Curiae brief with the Supreme Court of the United States in the case Rutledge v. Pharmaceutical Care Management Association on behalf of the Community Oncology Alliance (COA) and several leading community oncology practices supporting state regulation of pharmacy benefit managers (PBMs) and advocating on behalf of cancer patients and oncologists throughout the United States.

The Amicus Curiae brief brings to the Supreme Court’s attention the unique perspective of community oncology practices, articulates the various ways that PBMs have interfered with optimal cancer care, and the importance of preserving the right of the states “to protect the health and well-being of their respective citizens.”

“The Constitution and Supreme Court precedent make clear that protecting the health and well-being of citizens is properly in the hands of the state lawmakers. It is critical that states have the right to enact laws protecting both patients and providers from PBM abuse,” said Jonathan E. Levitt, Esq., a founding partner of Frier Levitt. “I am honored to have worked alongside COA and these brave practices, to ensure that the interests of cancer patients and oncologists were heard by the Supreme Court at this critical moment.”

The Petitioner in this case is the Arkansas Attorney General, Leslie Rutledge and the Respondent is powerful PBM lobbying group Pharmaceutical Care Management Association (PCMA). The specific law at issue in Rutledge is Arkansas’s Act 900, which is a comprehensive piece of legislation enacted by Arkansas in 2015 to combat improper PBM practices, including “low-ball” reimbursement tactics. Once Arkansas passed Act 900, PCMA quickly sued the State of Arkansas arguing that the legislation was preempted by ERISA. After a series of appeals by the parties, the Supreme Court determined that it would hear the merits of the case, which provided the opportunity for community oncology practices to provide their unique and important perspective on the case by filing an Amicus Curiae brief.

The Amicus Curiae brief filed on behalf of COA and six other prominent community oncology practices discusses several important issues that are often overlooked in the ongoing battle between healthcare providers, including oncologists, and PBMs, such as the advent of oral cancer drugs combined with a highly consolidated PBM landscape. The brief notes that “the increased development, availability, and use of oral cancer drugs” has “catalyzed PBMs’ shifting of patients from Community Oncology Practices to PBM-owned mail order pharmacies.” The brief further notes that based on the development of oral cancer drugs “PBMs have aggressively entered the oral cancer drug ‘market’” to the detriment of patients throughout the country. The Rutledge case is scheduled for oral argument on April 27, 2020.

Read the Amicus Curiae brief filed by Frier Levitt on behalf of COA and community oncology practices at: https://bit.ly/2PSKDu2.

About Frier Levitt

Frier Levitt is a national boutique healthcare law firm located in Pine Brook, New Jersey. Our nearly 40 attorneys bring collective experience and backgrounds in pharmacy, hospital administration, professional licensing, Attorney General actions, clinical practice, and medical billing. We provide comprehensive legal services to healthcare providers, including physician groups, laboratories, surgery and imaging centers, Compounding and Specialty Pharmacies, Outsourcing Facilities, chemical manufacturers, repackagers, wholesalers, group purchasing organizations, buying groups, and other healthcare related businesses. Frier Levitt is uniquely positioned to serve as a guide to healthcare providers, offering a broad and deep understanding of federal and state healthcare laws and regulations and the industry as a whole. Learn more at: http://www.frierlevitt.com

Share article on social media or email:

Gareda Home Care Services Selects CareAcademy as their Trusted Training Provider for Thousands of Caregivers


Our partnership with CareAcademy allows us to go beyond just an online training program and focus on growing our business by investing in the learning, upskilling, and development of our most precious resource, our caregivers.

Gareda Home Care Services, one of the largest independently-owned, non-medical home care agencies in Illinois, employing over 2500 Home Care Aides, announced today they’ve selected CareAcademy as their trusted caregiver training solution.

Gareda has been serving Illinois for nearly 40 years, providing exceptional home care services to its clients. Gareda employs dedicated Home Care Aides that are thoroughly evaluated and screened and undergo extensive training. Gareda switched from an online training provider to CareAcademy’s learning and development platform because of CareAcademy’s demonstrated ability to improve onboarding and provide superior technology, content, and service. CareAcademy will serve as the platform to deliver interpersonal, compliance, and caregiver skills education in support of Gareda’s in-home care training programs.

“Our partnership with CareAcademy allows us to go beyond just an online training program and focus on growing our business by investing in the learning, upskilling, and development of our most precious resource, our caregivers. CareAcademy’s superior but simple technology, content, and service allows our business to continue to scale while providing the highest quality care to our clients,” said Ella Grays, Chief Executive Officer of Gareda. “As innovators in this space, we know that better technology and high-quality classes will help us as we grow. To that end, we’re extremely excited to provide CareAcademy’s high-quality training to our thousands of caregivers, enabling them to provide top notch care to our clients.”

“Gareda’s leadership team is a pillar of the Illinois community at large, and particularly the Illinois Association of Community Care Program Homecare Providers community. We’re thrilled to be the new solution of choice to help Gareda streamline many HR functions and prepare the right quality caregiver to work with any client, at any time, to meet the growing demand,” says Helen Adeosun, CEO and Co-founder of CareAcademy. “Our best-in-class software and learning modules enable owners and managers to upskill workers for health needs and even certify new health workers in a range of skills to reduce their shortage of qualified workers.”

CareAcademy helps home care agencies grow faster and effortlessly maintain compliance with engaging online caregiver learning and easy-to-use technology. CareAcademy has been shown to reduce caregiver onboarding time by up to 60%, driving higher revenues for home care agencies. CareAcademy offers high-quality caregiver training on an easy-to-use platform that automatically assigns the right training at the right time. Caregivers take engaging, bite-sized video classes on their smartphones. As a result of the class accessibility, platform features like text and email reminders, and simple but powerful technology, classes have a 90%+ completion rate. Home care agencies have the opportunity to access nearly 160 hours of mobile-friendly video training to meet state requirements, upskill their caregivers, and quickly onboard caregivers for new clients.

About CareAcademy

Founded by caregivers, CareAcademy creates online training that empowers senior care professionals to deliver the highest caliber of service and improve the lives of older adults. Over 70,000 caregivers are learning and growing professionally through CareAcademy. Coupled with its automated training compliance dashboard, CareAcademy is an end-to-end, scalable training solution that transforms home care businesses into efficient industry leaders. To learn more, visit: http://www.CareAcademy.com.

About Gareda

Gareda has been serving Illinois with pride, care and expertise since 1981. Gareda’s quality in-home care services enable individuals to maintain in the comfort of their own home. Gareda upholds the worth and dignity of its diverse community of clients all while maintaining a family of dedicated employees by fostering an environment that integrates teamwork, integrity and unwavering professionalism. To learn more, visit: http://www.Gareda.com/

Share article on social media or email:

NeoTract Designates Dr. Jeffrey Sparenborg as UroLift® Center of Excellence


News Image

“We are proud to name Dr. Jeffrey Sparenborg as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Jeffrey Sparenborg, MD, Utah Valley Urology in Provo, UT, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Sparenborg has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Jeffrey Sparenborg as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Eyedaptic Extends Reach to those with Low Vision Through Partnership with Vispero


News Image

Enhancing Vision to Revitalize Life

Those with low vision and other retinal conditions will have an opportunity to regain the independence they once knew,” says Vispero Vice President, North America Sales, Richard Tapping.

Eyedaptic, Inc., a natural vision software company, announced today a joint partnership with Vispero, a leading assistive technology provider for the visually impaired, to expand its reach of visually assistive Augmented Reality (AR) devices. By partnering together, Eyedaptic & Vispero can offer broader access of their low vision solution to the community.

More than 250 million people are affected by retinal disease globally. Age Related Macular Degeneration (AMD) alone impacts more than 170 million people, urging low vision experts to find a real solution to address this growing need. Eyedaptic is a software technology company, focused on developing and marketing visually assistive Augmented Reality (AR) devices with embedded simulated natural vision software in open market hardware platforms. Their comfortable, wearable low vision aid works to enhance daily living for those with low vision, including those with AMD.

Eyedaptic and Vispero will be co-hosting a booth at this year’s CSUN Assistive Technology Conference at the Marriott in Anaheim, California, from March 11th to 13th. CSUN (Cal State University Northridge) 35th Assistive Technologies Conference provides an inclusive setting for researchers, practitioners, exhibitors, end users, speakers and other participants to share knowledge and best practices in the field of assistive technology. Visit booth #503/603/703 to learn more about gaining access to Eyedaptic technology.

Clinical data presented at last year’s CSUN conference validated how the Eyedaptic eyeglasses improve both visual acuity as well as tasks of daily living. The clinical data presented demonstrated marked improvements of visual acuity of two times and five times improvement in daily living tasks. Additionally, the glasses are comfortable and easy to wear while executing a wide variety of tasks under a range of conditions.

“Our eyewear offers the widest field of view with Augmented Reality (AR) on the market today, to improve the vision for those with Age Related Macular Degeneration (AMD) and other retinal challenges,” says Jay Cormier, Founder and CEO of Eyedaptic. “Through this partnership, we have the potential to reach more people struggling with the daily challenges that accompany low vision. This opportunity to share our technology with such a diverse crowd and get the word out on how we can improve millions of people’s lives is an honor.”

“We are excited about this opportunity to improve accessibility with state-of-the-art technology,” says Vispero Vice President, North America Sales, Richard Tapping. “Those with low vision and other retinal conditions will have an opportunity to regain the independence they once knew.”

About Eyedaptic

Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life. For more information, please contact info@eyedaptic.com.

About Vispero:

Vispero is the global leader for assistive technology products for those with vision impairments. Freedom Scientific, The Paciello Group, Enhanced Vision and Optelec, all Vispero brands, have a long history of innovation for customers with accessibility needs. Today our product portfolio is considered one of the most diverse and reliable on the market. For more information, visit http://www.vispero.com.

Media Contact:

Jay Cormier

Eyedaptic, Inc.

949-216-0816

jay.cormier@eyedaptic.com

Share article on social media or email:

Greenlight Guru Updates Risk Management Capabilities to Align with ISO 14971:2019, Further Enhances Change Management Capabilities


https://www.greenlight.guru/

“The update to our platform not only conforms to the new standard but represents our continued dedication to being the best quality management system for medical device companies.”

Greenlight Guru, the only medical device quality management system (MDQMS), today announced new software platform updates in order to align with the recently updated International Organization for Standardization (ISO) 14971:2019 standard, as well as further enhancements to the Change Management capabilities they debuted in December 2019.

ISO 14971 is the predominant standard for risk management in the medical device industry, of which compliance is required in the United States, Canada, and the European Union. Put into effect in December 2019, ISO 14971:2019 is the latest update to the application of risk management for medical devices. It serves to define better key terminology, residual risk identification, and personnel competence.

“This iteration of the ISO 14971 standard is the first update in nearly 13 years, and offers much-needed clarifications to reflect current best practices,” said Jon Speer, founder and VP of QA/RA at Greenlight Guru. “The update to our platform not only conforms to the new standard but represents our continued dedication to being the best quality management system for medical device companies.”

Greenlight Guru’s timely platform update to help medical device companies comply with these changing regulatory standards is proof that they eliminate the burden of allocating internal resources to update the design and quality processes for customers, allowing them to stay current with evolving industry regulations and compliance requirements.

Updates to the Greenlight Guru platform reflects changes to align with ISO 14971:2019, as well as several productivity enhancements, including:


  • Enhanced Change Management capabilities intended to assure medical device companies are systematically assessing the impact of changes through built-in change evaluation functionality
  • The debut of Group Management, which gives companies the flexibility to create & manage different Groups of employees based on how their teams or organization are uniquely structured

This announcement comes on the heels of significant enhancements to Greenlight Guru’s Change Management workflows, the launch of Digital Design Reviews, and the company’s fifth consecutive quarter as a G2 Crowd market leader in the quality management software category.

For more information about Greenlight Guru’s Risk Management capabilities, please visit https://www.greenlight.guru/risk-management-software.

About Greenlight Guru

Greenlight Guru is the only quality management software platform designed specifically for medical device companies. The platform helps companies bring safer products to market faster, simplifies FDA and ISO regulatory compliance and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits and more. Greenlight Guru’s platform is used by thousands of users across the globe to push beyond baseline compliance and achieve True Quality for their medical devices. For more information, visit http://www.greenlight.guru.

Media Contact

Kate Johnson

kate_johnson@BLASTmedia.com

(317) 806-1900

Share article on social media or email:

PrognoCIS EHR Announces Complimentary Telehealth Application To Its Existing Customers, in Their Fight to Treat and Contain Coronavirus


Current customers of PrognoCIS EHR will receive the Telehealth module along with the questionnaire for Coronavirus diagnosis (as per CDC guidelines) free until June 15, 2020.

Telehealth or remote care is a powerful platform for providing treatment and care in the recent Coronavirus outbreak. This technology is connecting the healthcare community with patients while ensuring safety for all – physicians, nurses, office staff, and patients.

Telehealth offers unique opportunities for physicians to quickly diagnose patients remotely, prescribe medication via e-prescriptions, monitor patient’s progress and provide access to care at all times..

In the event of self-containment, with telehealth, doctors can refer patients to appropriate clinics as needed. This helps fight and control infection and also allows patients to receive care in their homes without exposing them and others to further illness.

“We encourage our customers to utilize our telehealth module for enhanced provider-patient safety. Telemedicine is a useful platform to evaluate and reassure patients in the comfort of their own surroundings. Whether the provider is currently using telehealth or not, now is an opportunity to embrace and capitalize on its advantages” says Vinay Deshpande, CEO, Bizmatics Inc.

PrognoCIS took proactive measures from the onset of Coronavirus. In late January, they released patient questionnaire (as per CDC guidelines) within their EHR, to reflect the criteria for evaluation of Persons Under Investigation. This resource prepared physicians and their staff, to carry out diagnostic testing, clinical care, and further control the spread of infection.

According to media reports – The next few months are critical in the ongoing efforts to contain COVID-19 spread among communities. Telehealth will play a crucial role in preventing the spread of the virus which has so far been extremely contagious and hard to contain.

About Bizmatics: Bizmatics Inc. is a healthcare technology company serving the needs of Ambulatory Medical Practices of all sizes and specialties. PrognoCIS – their cloud-based EHR Software provides physicians with tools that promote quality and value-based care for their patients. PrognoCIS helps providers take utmost care of their patients by seamlessly integrating scheduling, documentation, billing and patient engagement. Some of the features that help achieve this herculean task include Practice Management, Medical Billing and Revenue Cycle Management, Telemedicine, Patient Portal, e-prescription and more.

PrognoCIS clients include physician practices, specialty medical centers, community health clinics, diagnostic laboratories, medical imaging centers, first responders and virtual clinics (telemedicine).

Media:

Deeya Ranjan

Marketing Manager

Bizmatics Inc

dranjan@bizmaticsinc.com

408.873.3030 x 217

Share article on social media or email: